Orphazyme ApS develops new therapies for the treatment of rare and genetic diseases. Its core program is to develop heat shock protein based therapies for the treatment of diseases caused by defects in the function and/or metabolism of proteins.
If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact email@example.com or +45 5150 0560
Copyright 2011 Danskbiotek. All rights reserved.
created by: Mastafu Design